The Institute for Clinical Effectiveness Review (ICER) has been making a name for itself as it undertakes value assessment of new medicines. The Institute has been working for over ten years, and not everyone has been supportive of their work. One of the criticisms has been a lack of transparencOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.